Although the relationship between polymorphisms in microRNAs (miRNAs) and recurrent pregnancy loss (RPL) has been studied, there is very little data available in the literature. In the present study, we scanned 55 potentially functional polymorphisms in the miRNA coding region in Chinese women with unexplained RPL (URPL; no. 2011-10). The rs6505162 COA in the MIR423 coding region was found to be significantly associated with the occurrence of human URPL. The rare A allele contributed to an increase in the expression of mature MIR423. C to A substitution in the polymorphism rs6505162 in pre-MIR423 repressed cell proliferation and migratory capacity. Further investigations showed that MIR423 could inversely regulate the expression of proliferation-associated 2 group 4 (PA2G4) by binding the 3 0 -UTR of PA2G4. Dual-luciferase assay indicated that the A allele in the polymorphism rs6505162 could more effectively suppress the expression of PA2G4 than the C allele could. Collectively, the present data suggest that rs6505162 COA in pre-MIR423 may contribute to the genetic predisposition to RPL by disrupting the production of mature MIR423 and its target gene, which consequently interferes with MIR423 functioning.
Introduction
Early pregnancy loss is the most common complication in human reproduction, with an incidence that ranges from 50 to 70% of all conceptions (Rai & Regan 2006) . Up to 5% of women experience early spontaneous pregnancy loss at least twice. Recurrent pregnancy loss (RPL) has been defined as two or more consecutive pregnancy losses (Practice Committee of American Society for Reproductive Medicine 2013). The known risk factors for RPL include advanced maternal age, maternal anatomic anomalies, chromosomal abnormalities, endocrine dysfunction, immunologic problems, environmental factors, and anti-phospholipid antibody syndrome (Rai & Regan 2006) . In w50% of cases, the cause is not identified; this is defined as unexplained RPL (URPL), and it may result in an increased risk of women developing clinical depression and anxiety (Regan & Rai 2000 , Craig et al. 2002 .
MicroRNAs (miRNAs) are small but powerful noncoding RNA molecules that function as negative regulators of the expression of their target genes (Hinske et al. 2010) . Most metazoan miRNAs bind to the 3 0 -UTRs of target mRNAs; however, there are also cases in which miRNAs regulate mRNA targets through binding sites in 5
0 -UTRs or coding regions (Kloosterman et al. 2004 , Lytle et al. 2007 . Increasing evidence has shown that single nucleotide polymorphisms (SNPs) or mutations in miRNA coding regions may alter miRNA expression and/ or maturation, which may affect the occurrence of diseases (Saunders et al. 2007 , Jazdzewski et al. 2008 . Our previous report (Hu et al. 2011) showed that two SNP sites in the pre-MIR125A coding region are related to human RPL, which means that miRNAs might play an important role in the occurrence of RPL.
In the present study, in order to obtain a better understanding of the relationship between miRNA polymorphisms and PRL, 55 potentially functional polymorphisms were investigated in a case-control study in RPL patients from northern China. Adjusted odds ratios (ORs) were used to calculate the association between miRNA polymorphisms and PRL. The functional significance of the polymorphism of rs6505162 in the MIR423 coding region was studied. To our knowledge, the present study is the first to systematically evaluate the impact of genetic polymorphisms in miRNA coding genes on the risk of RPL.
Materials and methods

Subjects
One hundred and seventy-five RPL patients with two or more consecutive spontaneous abortions and 201 healthy controls were recruited from Ningxia Medical University. Two or more consecutive missed abortions was considered as RPL. The decidual tissues of 11 patients with two or more consecutive missed abortions and 11 healthy pregnant time-matched controls were collected from the Sixth Hospital of Shijiazhuang. The decidual tissues from the control group were mainly derived from therapeutic abortions that were executed when there was a severe threat to the mother 0 s health or life, such as an accident or a serious pregnancy response. We excluded many factors that were likely to cause this medical condition by blood tests of the maternal blood, including a virus infection (TORCH) test, an immune antibodies test, and measurements of glucose levels, tri-iodothyronine/thyroxine/thyrotropin, and sex hormone levels. We also checked the couple's chromosomal karyotype and blood type, and we performed an ultrasound scan to confirm that there were no anomalies in the reproductive system. In addition, we carried out routine semen analysis to confirm that there were no potential confounding factors from the patients' partners. Finally, we excluded any patients who had genetic defects or hereditary diseases in their family history. The controls were individuals that had normal ovary and uterus morphology, regular menstrual cycles, and normal reproductive functioning without a history of subfertility treatment. The present study was approved by the Ethics Committee of the Research Institute for Family Planning (no. 2011-10), and informed consent was obtained from all of the participants.
Genotyping
Genomic DNA was extracted from whole-blood samples using the Qiagen Blood Kit (Qiagen), according to the manufacturer's instructions. After extraction, genomic DNA was diluted to a final concentration of 15-20 ng/ml for the genotyping assays. Fifty-five SNPs in the hairpins of the pre-miRNA coding region were selected, and they included 16 sites in the mature miRNA coding region, 18 SNPs in the miRNA complementary sequence of mature miRNA, 12 SNPs in the loop, and nine SNPs in the basal stem (Table 1 ). The SNPs in the pre-miRNA coding region were analyzed by allele-specific MALDI-TOF mass spectrometry assay using the Sequenom (San Diego, CA, USA) MassARRAY iPLEX platform (Jurinke et al. 2002) . Primers for the amplification and extension reactions were designed using the MassARRAY Assay Design version 3.1 Software (Sequenom). SNP genotypes were obtained according to the iPLEX protocol provided by the manufacturer. Genotyping quality was examined by a detailed QC procedure that consisted of a O95% successful call rate, the duplicate calling of genotypes, internal positive control samples, and Hardy-Weinberg equilibrium (HWE) testing.
Secondary structure prediction
The secondary structure of the pre-miRNA sequence was predicted using the RNAfold webserver (http://rna.tbi.univie. ac.at/cgi-bin/RNAfold.cgi).
Plasmid construction and transfection
To construct pre-MIR423 and its SNPs vectors, fragments that corresponded to pre-MIR423 and its flanking regions were amplified from human genomic DNA and cloned into the pCR3.1 vector (Invitrogen). The sequences of the vectors were confirmed by direct sequencing, and the only difference was in the SNP sites. The pCR3.1-based plasmid, MIR423 mimic, and MIR423 inhibitor were transfected into cells by using lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. To generate 3 0 -UTR luciferase reporter, a partial sequence of the 3 0 -UTR from PA2G4 was cloned into the pGLO vector (Promega; designated as wt-PA2G4). Mutant MIR423 target sites in the 3 0 -UTR of PA2G4 were used as corresponding controls (designated as mut-PA2G4). The Pa2g4 3 0 -UTR and PA2G4 3 0 -UTR mutant sequences were amplified by PCR from human genomic DNA using the following primers: wt-PA2G4-SacI forward: GAGAGCTC-CAACCACGGAAGACTACTTTA, wt-PA2G4-XbaI reverse: GACTCTAGATAAATGAAGGCTCCAGCTCC; mut-PA2G4-SacI forward: ATTCAGGCTGTCCAGTCAGGTATCTCCGATTTT, mut-PA2G4-XbaI reverse: ATACCTGACTGGACAGCCTGAAT-CAGATGAGGA. After being double-digested with SacI and XbaI, the PCR products were cloned into the downstream of the stop codon of the luciferases gene in the pGLO vector, and the constructs were verified by sequencing.
Quantitative RT-PCR
Total RNA was extracted using Trizol reagent (Invitrogen). The expression of MIR423 was detected by TaqMan miRNA Real-Time RT-PCR. Total RNA was reverse-transcribed by the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems). The acquired single-strand cDNA were amplified by the TaqMan Universal PCR Master Mix (Applied Biosystems) and by the miRNA-specific TaqMan MGB probes for MIR423 and U6 (Applied Biosystems). The U6 was used as an internal control. The expression of PA2G4 was detected by real-time RT-PCR. Total RNA was reverse-transcribed by the iScript cDNA Synthesis Kit (Bio-Rad). The single-strand cDNA were amplified by a FastStart Universal SYBR Green Master (Roche) and the following primers: forward:
0 . Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) was used as an endogenous control. Each sample in each group was tested in triplicate, and the experiment was repeated three times.
Cell proliferation assays
Cell proliferation was estimated by BrdU assay. HEC-1b cells were seeded in 24-well plates at low density (5!10 3 ) in DMEM culture and were allowed to attach overnight. The cells were then transfected with pre-MIR423 and its SNP vectors. There were three wells in each treatment group. After 48 h of transfection, the cells were incubated with rat monoclonal anti-BrdU (1:400; Abcam, Cambridge, UK) and then with Alexa Fluor 594 donkey anti-rat IgG (1:200; Invitrogen). Cells were viewed under an Eclipse TE2000-U fluorescence microscope (Nikon). To evaluate the specificity of the antibodies, negative control staining was performed by substituting normal rat serum for the primary antibody.
Flow cytometry analysis
Cell apoptosis was detected by flow cytometry analysis. We harvested the cells after 48 h of transfection. Annexin V-FITC, binding buffer, and PI were proportionally mixed. Fifty microliters of mixture was added to each sample, which was then incubated for 15 min at room temperature. The samples were analyzed at a rate of 8000 events per second by flow cytometry (BD Biosciences, San Diego, CA, USA). Each treatment was repeated twice, and the experiment was repeated three times.
Cell migration and invasion assays
HEC-1b cells were transfected with pCR3.1, pCR3.1-MIR423-C/C, pCR3.1-MIR423-A/A, or pCR3.1-MIR423-C/A. Cells were 
* Represents the passenger strand.
SNP in MIR423 and recurrent pregnancy loss ), which were contained in 0.5 ml media without serum or growth factors, were added to the top of 8 mm porous chamber inserts (Corning, Corning, NY, USA) and placed in wells filled with 0.75 ml of medium supplemented with 10% FCS for the migration assays. Matrigel (BD Biosciences) was added to the top of 8 mm porous membrane chambers (Corning) and incubated at room temperature until the matrigel solidified; then, cells (1!10 5 ) were seeded on top of the matrigel-coated membrane for the invasion assays. After 20 h of incubation, the cells that remained on the insert top layers were removed with a cotton swab as recommended by the manufacturer. Cells in the bottom of the 8 mm porous chamber inserts were fixed by 4% paraformaldehyde solution (Sigma-Aldrich) and stained with hematoxylin and eosin (Sigma-Aldrich). The membranes were photographed under a light microscope, and the cells that passed through the membrane were counted from five different fields per sample, which were selected in a random manner, at 200! magnification.
Dual-luciferase assay
293T cells were seeded in 48-well plates overnight and then transfected by lipofectamine 2000 (Invitrogen). Two days later, the cells were harvested and assayed with the dual-luciferase assay (Promega). Each treatment was performed in triplicate, and there were three independent experiments. The results are expressed as relative luciferase activity (firefly luc/renilla luc).
Statistical analysis
The HWE was determined using a standard c 2 test (dfZ1) to compare the observed frequency with the expected frequency in controls. Allele and genotype frequencies and ORs were calculated online using the SHEsis Software platform (http:// analysis.bio-x.cn) (Shi & He 2005 , Li et al. 2009 ). The data from the qRT-PCR, cell proliferation, migration, invasion, and dualluciferase assays were analyzed by one-way ANOVA followed by an least significant difference post hoc test and Tukey's test using SPSS Software version 16.0 (SPSS, Inc.) . The values are shown as meansGS.E.M. The differences were considered statistically significant at P!0.05.
Results
Genetic case-control association study
To explore the relationship between miRNA SNPs and URPL, the genotyping of 55 SNPs in the pre-miRNA coding region were analyzed by allele-specific MALDI-TOF mass spectrometry assay using the Sequenom MassARRAY iPLEX platform. The genotyping success rate was 96.7%. The genotype frequencies of rs6505162 of MIR423, rs62030476 of MIR1826, and rs9913045 of MIR548H3 were not significantly different among the controls, as measured by HWE (PZ0.45, 0.92, 0.97 respectively). The allele frequencies and associated ORs (95% CIs) for the RPL cases and controls are presented in Table 2 . Significant differences were found in the allele distributions of these three SNPs (P!0.01, P!0.01, and PZ0.041 respectively). Overall, the variant A allele of rs6505162 (OR 1.68, 95% CI 1.14-2.46), the G allele of rs62030476 (OR 6.72, 95% CI 2.49-18.09), and the A allele of rs9913045 (OR 1.42, 95% CI 1.01-2.00) were associated with an increased risk of RPL as compared to the control group.
MIR423 secondary structure prediction
Recent studies have shown that MIR1826 is not an miRNA (http://www.mirbase.org/cgi-bin/mirna_summary. pl?orgZhsa), so we did not predict the secondary structure of MIR1826. The secondary structures of about 500 bp pre-MIR423 and pre-MIR548H3 sequences, including pre-miRNAs and 200 bp upstream and downstream, were predicted using the RNAfold webserver (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold. cgi). The rare allele A in pre-MIR423 caused an apparent change in loop size and structure as well as a decrease in the predicted DG from K135.50 to K119.35 kcal/mol (Fig. 1A) . However, the predicted secondary structure and DG were not significantly different between the G allele and the A allele in pre-MIR548H3 (Fig. 1B) . DG here refers to the free energy of the thermodynamic ensemble, which in some sense represents the thermodynamic stability of the secondary structure. Therefore, we speculate that rs6505162 in pre-MIR423 may impact the function of mature MIR423.
MIR423 rs6505162 affects MIR423 expression
Because the SNP rs6505162 was located in the pre-MIR423 coding region, we speculated whether the SNP rs6505162 could alter the production of mature MIR423. The effects of C/A polymorphism of rs6505162 on the production of mature MIR423 were analyzed by TaqMan miRNA Real-Time RT-PCR (Fig. 2) . The expression levels of mature MIR423 in the CC homozygote (P!0.05), AA homozygote (P!0.01), and C/A heterozygosity (P!0.01) were significantly higher than that in the pCR3.1 empty vector, which implies that the constructs of WT and mutant MIR423 could effectively produce mature MIR423. The AA homozygote obviously enhanced the expression level of mature MIR423 as compared to the CC homozygote (P!0.01). Although the mature MIR423 level is lower in C/A heterozygosity of rs6505162 than it is in the AA homozygote, it was significantly increased by C/A heterozygosity of rs6505162 as compared to the CC homozygote (P!0.01). These results suggest that C to A substitution in rs6505162 of MIR423 promotes the production of mature MIR423.
C to A substitution in the rs6505162 polymorphism inhibits cell proliferation HEC-1b cells were transfected with pCR3.1, pCR3.1-MIR423-C/C, pCR3.1-MIR423-A/A, or pCR3.1-MIR423-C/A. After 48 h, cell proliferation was determined by BrdU assay (Fig. 3) . The proliferation ability in the AA homozygote was significantly lower than that in the CC homozygote (P!0.01) and the empty pCR3.1 vector (P!0.01). C/A heterozygosity of rs6505162 may better facilitate cell viability as compared to the AA homozygote (P!0.01), whereas the cell proliferation ability in the C/A heterozygosity of rs6505162 was equal to that in the CC homozygote and the empty pCR3.1 vector. These results suggest an association of A allele with the inhibition of cell viability.
MIR423 rs6505162 impacts cell apoptosis
To further explore the role of rs6505162 of MIR423 in controlling cell growth, cell apoptosis was determined by flow cytometry analysis (Fig. 4) . The percentages of early apoptotic cells (annexin V-FITC-positive) transfected with pCR3.1, pCR3.1-MIR423-C/C, pCR3.1-MIR423-A/A, or pCR3.1-MIR423-C/A were about 6.0, 4.0, 2.5, and 1.9%, respectively. The percentages of late apoptotic cells (annexin VFITC/PIpositive) transfected with pCR3.1, pCR3.1-MIR423-C/C, pCR3.1-MIR423-A/A, and pCR3.1-MIR423-C/A were about 1.9, 1.4, 1.2, and 0.8% respectively. These results show that rs6505162 of MIR423 has no significant effect on cell apoptosis.
MIR423 rs6505162 impacts cell migration and invasion
To further research the effect of MIR423 rs6505162 on cell behavior, we analyzed the influence of MIR423 rs6505162 on cell migration and invasion (Figs 5 and 6 ). The CC homozygote had no significant effect on cell migratory capacity in HEC-1b cells. The AA homozygote reduced cell migratory capacity as compared to the CC homozygote, but this finding was not statistically significant. However, cell migratory capacity was significantly inhibited by the C/A heterozygosity of rs6505162 as compared to the CC homozygote and the empty vector (P!0.01; Fig. 5 ). Additionally, the invasion assay indicated that the invasive capacity was not significantly different among the CC homozygote, the AA homozygote, and the C/A heterozygosity of rs6505162 (Fig. 6 ). These findings suggest that MIR423 rs6505162 may suppress cell migration.
MIR423 affects the expression of PA2G4 in HEC-1b in vitro
To analyze the possible molecular mechanisms in which MIR423 is involved, its target genes were studied. An online search of MIR423 targets in the TargetScan (www. targetscan.org), miRDB (http://mirdb.org/miRDB/index. html), and miRanda (http://www.microrna.org) databases showed that there was a conservative 7nt MIR423 responsive element in the 3 0 -UTR of PA2G4 (Fig. 7A) . A key role of miRNA is to regulate the expression of target genes, so we analyzed the expression pattern of PA2G4 when MIR423 levels were altered.
HEC-1b cells were transfected with MIR423 mimic or inhibitor to analyze the effects of MIR423 expression on endogenous PA2G4 expression. PA2G4 protein levels detected by western blot were significantly downregulated by MIR423 mimic as compared to pre-MIR control (P!0.05), they were and up-regulated by MIR423 inhibitor as compared to anti-MIR control (P!0.05; Fig. 8A ). Furthermore, qRT-PCR was used to detect PA2G4 mRNA levels. MIR423 mimic significantly decreased PA2G4 mRNA levels (P!0.01), whereas MIR423 inhibitor markedly increased PA2G4 mRNA levels (P!0.01; Fig. 8B ). These findings show that the mRNA and protein levels of endogenous PA2G4 can be regulated by MIR423.
MIR423 directly targets the 3 0 -UTR of PA2G4
To validate PA2G4 as the direct target of MIR423, we established a luciferase reporter assay system. The 3 0 -UTR of PA2G4, which contains MIR423 target sites, was PCR-amplified from human genomic DNA and cloned into pmirGLO. MIR423 mimic and inhibitor were co-transfected with wt-PA2G4 (Fig. 7B) . Compared to the pre-MIR control, the luciferase activity was significantly decreased by the MIR423 mimic (P!0.01). When cells were transfected with the MIR423 inhibitor, the luciferase activity had an obvious upward trend as compared to the anti-MIR control. In order to confirm the binding sites for MIR423 in the 3 0 -UTR of PA2G4, we mutated the partial seed sequence in the 3 0 -UTR of PA2G4. As shown in Fig. 7C , co-transfections of MIR423 mimics and wt-PA2G4 significantly reduced the enzyme activity as compared to co-transfections of MIR423 mimics and mut-PA2G4 (P!0.01), which suggests that the mutation of the seed sequence could disrupt the binding of MIR423 to the 3 0 -UTR of PA2G4. All of these data show that PA2G4 may be the direct target gene of MIR423.
The expression pattern of PA2G4 in the decidual tissues in patients with two or more consecutive missed abortions
The expression levels of PA2G4 in the decidual tissues in patients with two or more consecutive missed abortions were detected by qRT-PCR and western blot (Fig. 9) . The mRNA level of PA2G4 was significantly decreased in the RPL group as compared to the control group (P!0.05).
The protein levels of PA2G4 were lower in the RPL group than they were in the control group, but this finding was not statistically significant.
MIR423 rs6505162 influences the expression of the MIR423 target gene
In the experiments described earlier in the present study, PA2G4 was confirmed to be the direct target gene of MIR423. The results from the TaqMan miRNA Real-Time RT-PCR showed that rs6505162 of MIR423 increases the expression of mature MIR423. In order to address the question of whether MIR423 rs6505162 can affect PA2G4 expression, the different genotypes of MIR423 rs6505162 were co-transfected with either wt-PA2G4 or mut-PA2G4 (Fig. 10) . Mut-PA2G4 was used as a negative control. Compared to the negative control, luciferase activity was significantly decreased in cells that were co-transfected with pCR3.1-MIR423-C/C, pCR3.1-MIR423-A/A, pCR3.1-MIR423-C/A, and wt-PA2G4 (P!0.01), which implies that the seed sequence in 3 0 -UTR of PA2G4 is specific to MIR423. When cells were co-transfected with wt-PA2G4 and the different genotypes of MIR423 rs6505162, the AA homozygote more significantly suppressed the luciferase activity than the CC homozygote did (P!0.01), and the C/A heterozygosity of rs6505162 slightly diminished luciferase activity as compared to the CC homozygote and increased luciferase activity as compared to AA homozygote. These results show that the A allele can effectively repress the expression of PA2G4 by up-regulating MIR423 levels.
Discussion
To our knowledge, the present study is the first to provide a general view of the relationship between potentially functional polymorphisms in pre-miRNAs and RPL susceptibility, although many SNPs in miRNAs sequences have been identified as having a strong relationship to disease (Saunders et al. 2007 , Hu et al. 2008 , Jazdzewski et al. 2008 .
The polymorphisms in miRNA precursors and the mature miRNA coding region may have more significant The prediction and confirmation of the MIR423 target gene. MIR423 binding sites in the 3 0 -UTR of PA2G4 were compared in cross-species (A). HEC-1b cells were co-transfected with a MIR423 mimic, a MIR423 inhibitor, a pre-MIR control, an anti-MIR control, and wt-PA2G4 for dualluciferase assay (B). HEC-1b cells were co-transfected with MIR423 and wt-or mut-PA2G4 for dual-luciferase assay (C). Mut-PA2G4 (mutating putative MIR423 binding region in the 3 0 -UTR of PA2G4) was used as a control. pRL-TK containing Renilla luciferase was co-transfected for data normalization. *P!0.05 and **P!0.01.
72 X Su, Y Hu and others effects on miRNA expression and function than do those in the primary miRNA coding region (Kontorovich et al. 2010) . Therefore, in the present study, we chose 55 SNPs in the hairpins of the pre-miRNA coding region in order to study the relationship between the polymorphisms of miRNAs and RPL susceptibility. The 55 SNPs are located in 54 miRNA coding regions. The reasons why we chose these miRNA SNPs were as follows: first, our previous experiments found that many of the miRNA SNPs listed in the NCBI's Short Genetic Variations database (dsSNP) do not exist in the Chinese population, so we chose miRNA SNPs that do exist in the Chinese population. For example, an SNP in MIR146A has been found to be associated with improved lung function and milder disease stages in Han Chinese people (Wang et al. 2015) . Likewise, rs4919510 in pre-MIR608 has been associated with increased recurrence-free survival in patients with colorectal cancer in Chinese people (Xing et al. 2012) . Second, implantation failure is one of major reasons for RPL. We therefore chose some miRNAs that have been shown to be differentially expressed in implantation vs pre-implantation rat uteri, such as MIR92A, MIR92B, MIR1268, and so on. (Xia et al. 2014a,b) . In addition, there are striking similarities in cell behavior between invasive trophoblastic cells during embryo implantation and invasive cancer cells (Murray & Lessey 1999) .
We consequently chose some miRNAs that have been shown to execute functions in tumorigenesis, such as MIR568, MIR1255B, MIR585, and so on (Hidaka et al. 2012 , Xiao et al. 2012 , Leidner et al. 2013 . The 55 miRNA SNPs were detected by allele-specific MALDI-TOF mass spectrometry assay. Significant differences were found in the allele distributions of MIR423 rs6505162, MIR1826 rs62030476, and MIR548H3 rs9913045 between RPL cases and controls. The prediction of a secondary structure showed that loop size, structure, and predicted DG were altered by the rare allele A in the pre-MIR423 coding region. However, the predicted secondary structure and DG were not significantly different between the G allele and the A allele in pre-MIR548H3. In addition, recent studies have shown that MIR1826 is not an miRNA (http://www. mirbase.org/cgi-bin/mirna_summary.pl?orgZhsa). Therefore, we chose to study rs6505162 in pre-MIR423.
The SNP rs6505162 is located in pre-MIR423, so we analyzed the impact of C/A polymorphism of rs6505162 on the production of mature MIR423. The expression level of MIR423 in the AA homozygote was markedly higher than that in the CC homozygote. Although the mature MIR423 level was lower in the C/A heterozygosity of rs6505162 than in the A allele, it was significantly increased by the C/A heterozygosity of rs6505162 as compared to the CC homozygote. These results suggest that the rare allele A in pre-MIR423 contributes to the production of mature MIR423, which is similar to the polymorphisms of MIR125A and has been shown to be associated with an increased risk of RPL in the Han Chinese population (Hu et al. 2011) . The rs6505162 C OA in MIR423 has been identified as a biomarker for many diseases. For example, Smith et al. (2012) showed than the C OA polymorphism located in the pre-miRNA region of MIR423 is associated with reduced breast cancer. Rs6505162 in pre-MIR423 was also identified as being significantly associated with recurrence-free survival and overall survival in patients with colorectal cancer (Xing et al. 2012) . Hsa-MIR423 rs6505162 C OA might also be associated with a significantly increased risk of esophageal squamous cell carcinoma in patients who smoke (Yin et al. 2013) . Additionally, MIR423 COA has been associated with an increased risk of primary ovarian insufficiency (Rah et al. 2015) . These previous studies imply that MIR423 rs6505162 has the potential to become a biomarker for the diagnosis of many clinical diseases. In the present study, the effects of MIR423 rs6505162 on cell behavior were investigated in order to better understand the functional significance of the polymorphism of rs6505162 in the MIR423 coding region. BrdU assay indicated that mutant MIR423 (an AA homozygote) exhibited significantly lower proliferation ability than that of WT MIR423 (a CC homozygote). The apoptosis levels of HEC-1b were not significantly different among the CC homozygote, AA homozygote, and C/A heterozygosity of rs6505162. The cell migratory capacity was reduced by mutant MIR423 as compared to WT MIR423. However, rs6505162 of MIR423 did not have a significant effect on cell invasive capacity. All of these results show that C to A substitution in MIR423 rs6505162 inhibits cell proliferation and migratory capacity.
To further explore the possible molecular mechanisms by which MIR423 rs6505162 regulates MIR423 function, we analyzed the binding status of MIR423 rs6505162 and its target gene by luciferase reporter assay. An online search of MIR423 targets in the TargetScan, miRDB, and miRanda databases provided a large number of putative mRNA targets. Among them, we focused on PA2G4 for the following reasons: i) the TargetScan, miRDB, and miRanda predictions all showed that there was one MIR423 responsive element in the 3 0 -UTR of PA2G4; ii) because MIR423 rs6505162 can affect cell proliferation, we chose target genes of MIR423 near proliferationrelated proteins. It has been reported that PA2G4 is involved in cell proliferation (Radomski & Jost 1995) ; iii) we found that PA2G4 expression was down-regulated by the MIR423 mimic, but the expression level of PA2G4 was up-regulated by the MIR423 inhibitor. Thus, PA2G4 levels were inverted with MIR423 levels.
A luciferase reporter assay was used to validate whether MIR423 directly targeted PA2G4. In the luciferase assay of transfection with wt-PA2G4, luciferase activity was decreased by the MIR423 mimic and increased by the MIR423 inhibitor, which suggests that the dysregulation of MIR423 influenced the binding of MIR423 and the 3 0 -UTR of PA2G4. Mutating seed sequence experiments confirmed that the binding sites in the 3 0 -UTR of PA2G4 were specific for MIR423. These results confirmed that PA2G4 is the direct target gene of MIR423. When HEC-1b cells were co-transfected with wt-PA2G4 and a CC homozygote, an AA homozygote, or a C/A heterozygosity of rs6505162, the luciferase activity was more significantly inhibited by the AA homozygote than it was by the CC homozygote, which suggests that the A allele could more effectively suppress the expression of PA2G4 than the C allele could.
PA2G4 (also known as EBP1, HG4-1, p38-2G4) has been defined as a novel cell cycle specifically modified and proliferation-associated nuclear protein in mammals (Radomski & Jost 1995) . Pa2g4 knockout in mice decreased the expression of insulin-like growth factor 1 (Igf1) and increased the expression of growth factor receptor bound protein 10 (Grb10) (Zhang et al. 2008) . Igf1 has been shown to play a critical role in placental function, which stimulates extravillous trophoblast (EVT) cell migration and invasion and thereby influences placental development and fetal growth. Insufficient 74 X Su, Y Hu and others invasion of EVT cells into the endometrium leads to pregnancy-related complications, including pregnancy loss (Kabir-Salmani et al. 2002 , Mayama et al. 2013 . Grb10 encodes a signaling adapter protein, is expressed predominantly from the maternally inherited allele, and acts to restrict fetal and placental growth (Charalambous et al. 2010) .Grb10 expression in term placenta is significantly negatively correlated with head circumference (Moore et al. 2015) . Our previous study showed that Grb10 expression was decreased in rat uteruses during embryo implantation by Mir199A and was not beneficial to endometrial development (Xia et al. 2014a,b) . In the present study, we confirmed that PA2G4 is the direct target gene of MIR423 and is reversely regulated by MIR423. The results from the TaqMan miRNA Real-Time RT-PCR showed that C to A substitution in MIR423 rs6505162 promoted the expression of mature MIR423. Additionally, we found that the expression of PA2G4 was diminished in the decidual tissues of patients with two or more consecutive missed abortions. According to the published reports, the down-regulation of PA2G4 may suppress IGF1 expression and enhance GRB10 levels. Therefore, we speculate that the down-regulation of PA2G4 by C to A substitution in MIR423 rs6505162 may result in an insufficient invasion of EVT cells into the endometrium as well as abnormal placental and endometrial development by down-regulating IGF1 and up-regulating GRB10, and this can then lead to spontaneous abortion.
Conclusion
In conclusion, we established the first association between SNPs in MIR423 and the risk of URPL in a northern Chinese Han population by identifying one functional SNP site in pre-MIR423. These findings may provide insight into our understanding of URPL pathogenesis and may suggest a new biomarker for the diagnosis of URPL.
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